NCT05238831 2024-01-23SMMART Adaptive Clinical Treatment (ACT) TrialOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Withdrawn
NCT02115828 2018-07-20A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor BiopsySidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase EARLY_PHASE1 Completed9 enrolled 10 charts